Biotech | 10 September 2025
Evonik and Ethris partner to expand offerings for nucleic acid delivery
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
Collaboration reinforces Boehringer Ingelheim’s expertise in microbial contract development and manufacturing
Astaxanthin is a powerful antioxidant and red-orange carotenoid pigment found in various aquatic organisms
The randomized, double-blind, placebo-controlled Phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102 in healthy participants
The therapy delivers the full-length ABCA4 protein and has the potential to benefit all patients with ABCA4 mutations
Under an exclusive distribution agreement, Sartorius Stedim Biotech will offer Nanotein’s lead products globally
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
Addresses brain metastases harboring BRCA1/2 and/or HRR alterations—an area of high unmet need
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
Capstan's lead asset, CPTX2309, is a targeted lipid nanoparticle (tLNP) that delivers an mRNA encoding an anti-CD19 chimeric antigen receptor (CAR) to CD8-expressing cytotoxic T cells in vivo
The NovaSeq X system features Illumina's cutting-edge XLEAP-SBS chemistry, offering unmatched throughput, accuracy, and sustainability
Ingredion will have exclusive access to Amyris’ technology to manufacture and sell fermented Reb M
Access to NIPT, TB and Rare Disease diagnostics to benefit thousands of patients nationwide
This collaboration positions WACKER and RNAV8 as premium mRNA service providers
Subscribe To Our Newsletter & Stay Updated
